GE Healthcare Technologies, a spinoff of General Electric, has reported potential violations of the Foreign Corrupt Practices Act (FCPA) in its China-based operations. The disclosure was made in the company's quarterly filing with the United States Securities and Exchange Commission (SEC) on Ootober 31.
According to the filing, GE Healthcare identified "tender irregularities and other potential violations" related to its activities across multiple Chinese provinces. This marks the first instance that the company has publicly acknowledged possible FCPA violations.
This item is available in full to subscribers.
To continue reading, you will need to either log in to your subscriber account, below, or purchase a new subscription.
If you are a current subscriber, and had an account on our previous site, you already have an account. If you have not yet logged into our new site, click here to reset your password.
Otherwise, click here to view your options for subscribing.
Please log in to continue |